KZR-261 drug page Clinical trials

Trials with KZR-261

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
61Planned patients

Showing 1–1 of 1

KZR-261 in Subjects With Advanced Solid Malignancies
Ongoing, not recruiting Phase 1 61 patients NCT05047536

A first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of KZR-261, as well as identify the recommended Phase 2 dose (RP…

United States Sept 2021 – Dec 2026 Interventional